Treatment compliance in retinoblastoma management – An approach to identifying and addressing barriers, and assessing compliance rate

• Though economic constraints remain is a major barrier to retinoblastoma treatment compliance, other socio cultural barriers like reluctance for enucleation contribute to treatment noncompliance in low middle income country like India • Financial aid for treatment, travel and accommodation can mitigate some of the economic barriers. • Awareness and early detection initiatives along with intense counseling will help in addressing other barriers and improve retinoblastoma treatment compliance To identify causes of non-compliance and evaluate effectiveness of interventions in improving retinoblastoma (RB) treatment compliance. Retrospective observational analytical study. The staging and grouping of RB were determined according to International Retinoblastoma Staging System and the International Classification of Intraocular Retinoblastoma respectively. Medical records of RB patients treated at a North Indian tertiary ocular oncology center (July 2019–June 2022) were reviewed. Compliance was defined as adherence to treatment plans and timely follow-ups. Patients in Group 1 (July 2019–Dec 2020, n=60) received standard care, while Group 2 (Jan 2021–June 2022, n=86) additionally received financial, logistic, and counselling support. Compliance and treatment barriers, assessed through parental interviews, were compared. Both the groups had similar demographics. Compliance improved from 67% (Group 1) to 78% (Group 2). Major barriers included financial constraints (69%), refusal of enucleation (27%), family/social issues (14%), cultural beliefs (13%), and COVID-19 restrictions (9%). Additional support led to better treatment compliance, though the improvement was not statistically significant. Non-compliance persisted in 22% of patients, mainly due to advanced disease, reluctance to enucleation, and sociocultural challenges. Sustained improvements in compliance require community awareness, family education, and early detection strategies.

Authors

Institutions

Publication Details

Journal
AJO International
Published
2025-11-05
DOI
https://doi.org/10.1016/j.ajoint.2025.100197
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment compliance in retinoblastoma management – An approach to identifying and addressing barriers, and assessing compliance rate

Shirali Gokharu, Obaidur Rehman, Sima Das, Namita Kumari et al.
AJO International
Ocular Oncology and Treatments
article

Treatment compliance in retinoblastoma management – An approach to identifying and addressing barriers, and assessing compliance rate

Shirali Gokharu, Obaidur Rehman, Sima Das, Namita Kumari, Chhavi Gupta
article en

Abstract

• Though economic constraints remain is a major barrier to retinoblastoma treatment compliance, other socio cultural barriers like reluctance for enucleation contribute to treatment noncompliance in low middle income country like India • Financial aid for treatment, travel and accommodation can mitigate some of the economic barriers. • Awareness and early detection initiatives along with intense counseling will help in addressing other barriers and improve retinoblastoma treatment compliance To identify causes of non-compliance and evaluate effectiveness of interventions in improving retinoblastoma (RB) treatment compliance. Retrospective observational analytical study. The staging and grouping of RB were determined according to International Retinoblastoma Staging System and the International Classification of Intraocular Retinoblastoma respectively. Medical records of RB patients treated at a North Indian tertiary ocular oncology center (July 2019–June 2022) were reviewed. Compliance was defined as adherence to treatment plans and timely follow-ups. Patients in Group 1 (July 2019–Dec 2020, n=60) received standard care, while Group 2 (Jan 2021–June 2022, n=86) additionally received financial, logistic, and counselling support. Compliance and treatment barriers, assessed through parental interviews, were compared. Both the groups had similar demographics. Compliance improved from 67% (Group 1) to 78% (Group 2). Major barriers included financial constraints (69%), refusal of enucleation (27%), family/social issues (14%), cultural beliefs (13%), and COVID-19 restrictions (9%). Additional support led to better treatment compliance, though the improvement was not statistically significant. Non-compliance persisted in 22% of patients, mainly due to advanced disease, reluctance to enucleation, and sociocultural challenges. Sustained improvements in compliance require community awareness, family education, and early detection strategies.

AJO InternationalVol. 2(4)
Dr. Shroff’s Charity Eye Hospital (IN)
Openalex Percentile: Top 54%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.